about
MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines.Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin responseDifferentiation of African components of ancestry to stratify groups in a case-control study of a Brazilian urban population.Molecular targets related to inflammation and insulin resistance and potential interventionsABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib.Efflux and uptake transporters as determinants of statin response.Atorvastatin attenuation of ABCB1 expression is mediated by microRNA miR-491-3p in Caco-2 cells.Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patients.Role of microRNAs on the Regulation of Mitochondrial Biogenesis and Insulin Signaling in Skeletal Muscle.Down-regulation of ABCB1 transporter by atorvastatin in a human hepatoma cell line and in human peripheral blood mononuclear cells.Effects of atorvastatin on CYP3A4 and CYP3A5 mRNA expression in mononuclear cells and CYP3A activity in hypercholeresterolemic patients.ABCB1 and ABCC1 expression in peripheral mononuclear cells is influenced by gene polymorphisms and atorvastatin treatment.FENOFIBRATE REVERSES CHANGES INDUCED BY HIGH-FAT DIET ON METABOLISM IN MICE MUSCLE AND VISCERAL ADIPOCYTES.MyomiRs as Markers of Insulin Resistance and Decreased Myogenesis in Skeletal Muscle of Diet-Induced Obese Mice.Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells.Moderate exercise changes synaptic and cytoskeletal proteins in motor regions of the rat brain.Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells.CYP3A53A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia.Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.Effects of 15-deoxy-Delta12, 14 prostaglandin J2 and ciglitazone on human cancer cell cycle progression and death: the role of PPARgamma.Short-term, moderate exercise is capable of inducing structural, BDNF-independent hippocampal plasticity.Attenuation of obesity and insulin resistance by fish oil supplementation is associated with improved skeletal muscle mitochondrial function in mice fed a high-fat diet.Influence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patients.ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells.Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin responseAn update on efflux and uptake transporters as determinants of statin responseInfluence of CYP3A4 and CYP3A5 polymorphisms on tacrolimus and sirolimus exposure in stable kidney transplant recipientsInfluence of PCSK9 polymorphisms on plasma lipids and response to atorvastatin treatment in Brazilian subjectsThe Relevance of Thimet Oligopeptidase in the Regulation of Energy Metabolism and Diet-Induced ObesityPolyphenol-rich green tea extract induces thermogenesis in mice by a mechanism dependent on adiponectin signalingNO-Dependent Akt Inactivation by S-Nitrosylation as a Possible Mechanism of STZ-Induced Neuronal Insulin ResistanceMicroRNA miR-222 mediates pioglitazone beneficial effects on skeletal muscle of diet-induced obese miceAdiponectin is required for pioglitazone-induced improvements in hepatic steatosis in mice fed a high-fat diet
P50
Q35171243-4D77D9F5-1147-4D70-AC3F-6AD5D44D62E7Q35297067-BAAB0459-807C-43A4-BBF6-0AAEC606B514Q36041632-86D33E1F-1195-4290-A60D-0E2FBB719F49Q36294297-A6BB195F-D886-4D3A-B28B-F0541F5067A0Q37652283-07ACF4D5-DE26-4ADC-AE8E-E49B7F314762Q37724381-BA0460EE-4E97-4C01-9293-2BF5146E0344Q38749023-89A2591F-2508-481A-A819-6B1F4A2015A2Q38883433-6553E3BF-215C-4CC2-89CB-80202E4D1923Q38979526-5EEEEA94-A1B8-4CF5-B09E-7D7F060E834CQ40228555-506CF6FC-D3B1-4955-9482-E8C49C2A0221Q42435842-34016579-1025-4D64-A2B4-58F2DC9EB540Q42443032-07A3F75A-F8F5-4661-85FE-5EF2E61299A9Q42515389-E1DDDCC7-C83B-41B6-9B63-8178E8676CB5Q42534113-8508FBFF-0D44-41A5-B9D4-D86BD7E2717EQ42879835-367790BE-64ED-4B70-8B1E-3ED8CBB68ACDQ43528995-F8688252-2E2D-42B7-8439-351647B12B75Q44966819-FA39AE16-EA80-402F-8F40-6020CB726ACDQ46410827-7F5782FB-91B9-40A4-A8C2-F52A428FAAFFQ46623854-DFFD17D7-C365-4628-8E66-8B05CD4329C8Q46869685-CB80D275-B089-40DD-8E75-6299B3640B80Q48810066-FA6D0567-2CF0-46ED-B32E-670D7BCFE7F8Q50138375-CA646BEF-21C9-4D1A-98BB-5DEAF147C343Q51630999-58821916-194B-4434-8248-2F715A3E1E96Q54382456-A7167AFF-33B2-4FB1-9796-E1B6960D44F9Q57083795-BAFC5043-A5CA-4B1E-B18D-F7B83BF09F6BQ60644673-3FFF9777-6C9A-4807-ADF9-A1A5FF9A6AC8Q60644680-02D503DE-FD17-459F-8C57-0272E544E1F1Q60644684-B91BCE04-7865-42CA-AEDB-17531AF6B169Q89806150-72C46529-B8A2-4870-B06A-BE6B9FF715AEQ89973926-D0333F96-0970-4AD8-AC4F-37B701D9C268Q91160611-F6C6ABD9-2264-4A03-BC10-C108EDC7101AQ91465467-5FFBA635-9421-4D1A-BCAB-DD4160EC8782Q92605189-1BEE579F-B6DB-4729-AB6E-E9913A2DBA75
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Alice Cristina Rodrigues
@ast
Alice Cristina Rodrigues
@en
Alice Cristina Rodrigues
@es
Alice Cristina Rodrigues
@nl
type
label
Alice Cristina Rodrigues
@ast
Alice Cristina Rodrigues
@en
Alice Cristina Rodrigues
@es
Alice Cristina Rodrigues
@nl
prefLabel
Alice Cristina Rodrigues
@ast
Alice Cristina Rodrigues
@en
Alice Cristina Rodrigues
@es
Alice Cristina Rodrigues
@nl
P1053
N-8100-2013
P106
P1153
15053842000
P21
P2798
P31
P3829
P496
0000-0002-9005-033X